[HTML][HTML] Circle the cardiac remodeling with circRNAs

T Yang, T Long, T Du, Y Chen, Y Dong… - Frontiers in …, 2021 - frontiersin.org
Cardiac remodeling occurs after the heart is exposed to stress, which is manifested by
pathological processes such as cardiomyocyte hypertrophy and apoptosis, dendritic cells …

[HTML][HTML] The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy

Y Yan, R Tang, B Li, L Cheng, S Ye, T Yang, YC Han… - Molecular Therapy, 2021 - cell.com
Hypertrophic growth of cardiomyocytes is one of the major compensatory responses in the
heart after physiological or pathological stimulation. Protein synthesis enhancement, which …

[HTML][HTML] An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy

H Wang, Q Xu, C Zhao, Z Zhu, X Zhu… - … for ImmunoTherapy of …, 2020 - ncbi.nlm.nih.gov
Background Recent impressive advances in cancer immunotherapy have been largely
derived from cellular immunity. The role of humoral immunity in carcinogenesis has been …

Transcribed ultraconserved regions, Uc. 323, ameliorates cardiac hypertrophy by regulating the transcription of CPT1b (carnitine palmitoyl transferase 1b)

Y Sun, W Fan, R Xue, B Dong, Z Liang, C Chen, J Li… - …, 2020 - Am Heart Assoc
Transcribed ultraconserved regions (T-UCRs) are a novel class of long noncoding RNAs
transcribed from UCRs, which exhibit 100% DNA sequence conservation among humans …

[HTML][HTML] Inhibiting miR-22 alleviates cardiac dysfunction by regulating Sirt1 in septic cardiomyopathy

R Wang, Y Xu, W Zhang, Y Fang, T Yang… - Frontiers in Cell and …, 2021 - frontiersin.org
High morbidity and mortality are the most typical characteristics of septic cardiomyopathy.
We aimed to reveal the role of miR-22 in septic cardiomyopathy and to explore the …

[HTML][HTML] Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2

Y Sun, C Chen, R Xue, Y Wang, B Dong, J Li… - Theranostics, 2019 - ncbi.nlm.nih.gov
Rationale: An imbalance between protein synthesis and degradation is one of the
mechanisms of cardiac hypertrophy. Increased transcription in cardiomyocytes can lead to …

[HTML][HTML] Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure

Y Yan, T Long, Q Su, Y Wang, K Chen… - Frontiers in …, 2022 - frontiersin.org
Heart failure is characterized by the inability of the heart to pump effectively and generate
proper blood circulation to meet the body's needs; it is a devastating condition that affects …